Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of DW0929 in Primary Hypercholesterolemia
NCT02390375Phase 3Completed
- Sponsor
- Daewon Pharm
- Start
- Nov 2014
- Primary completion
- Apr 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of rosuvastatin, ezetimibe in hypercholesterolemia, sponsored by Daewon Pharm. Started Nov 2014; status: completed.
02
Drugs
rosuvastatinezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02390375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02390375.